Education
About Us
Working with TipRanks
Follow Us
Profound Medical (TSE:PRN)
:PRN
Earnings Data
Report Date
Mar 10, 2026After Close (Confirmed)
Period Ending
2025 (Q4)Consensus EPS Forecast
-0.39Last Year’s EPS
-0.28Same Quarter Last Year
Strong Buy
Based on 3 Analysts Ratings
Earnings Call Summary
Earnings Call Sentiment|Positive
The call presented a positive outlook with significant revenue growth, successful product launches, and increasing adoption of TULSA-PRO. However, challenges remain with ongoing operating losses and high expenses. The company is making progress toward profitability and has a strong sales pipeline, but future financing remains uncertain.Company Guidance
Significant Revenue Growth
Profound Medical recorded Q3 2025 revenue of $5.3 million, up 87% from $2.8 million in Q3 2024, with a gross margin increase to 74.3% from 63.1%.
TULSA-AI Volume Reduction Software Launch
The full product launch of TULSA-AI Volume Reduction software is set for the RSNA annual meeting, leveraging AI for efficient workflows in BPH treatment.
Growing TULSA-PRO Adoption and Pipeline
The number of TULSA-PRO sites increased to 70, with 93 new systems in the Verify, Negotiate, and Contracting stages of the sales process.
Commercial Success of TULSA-PRO
Strong traction with TULSA-PRO, supported by positive clinical outcomes and strategic partnerships, driving broader adoption across hospitals.
Positive Reimbursement Developments
Medicare and some commercial payers are providing coverage for TULSA-PRO procedures, with commercial payments ranging from $25,000 to $65,000 per patient.
TSE:PRN Earnings History
The table shows recent earnings report dates and whether the forecast was beat or missed. See the change in forecast and EPS from the previous year.
Beat
Missed
TSE:PRN Earnings-Related Price Changes
Report Date | Price 1 Day Before | Price 1 Day After | Percentage Change |
|---|---|---|---|
Nov 13, 2025 | C$9.04 | C$9.42 | +4.20% |
Aug 14, 2025 | C$7.54 | C$5.96 | -20.95% |
May 08, 2025 | C$6.90 | C$6.42 | -6.96% |
Mar 06, 2025 | C$10.34 | C$9.91 | -4.16% |
Earnings announcements can affect a stock’s price. This table shows the stock's price the day before and the day after recent earnings reports, including the percentage change.
FAQ
When does Profound Medical (TSE:PRN) report earnings?
Profound Medical (TSE:PRN) is schdueled to report earning on Mar 10, 2026, After Close (Confirmed).
What is Profound Medical (TSE:PRN) earnings time?
Profound Medical (TSE:PRN) earnings time is at Mar 10, 2026, After Close (Confirmed).
Where can I see when companies are reporting earnings?
You can see which companies are reporting today on our designated earnings calendar.
What companies are reporting earnings today?
You can see a list of the companies which are reporting today on TipRanks earnings calendar.
What is TSE:PRN EPS forecast?
TSE:PRN EPS forecast for the fiscal quarter 2025 (Q4) is -0.39.